Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Pharmacy benefit leaders at ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

The best way to address employers' concerns is to improve employee utilization of weight loss benefits, according to Saunders ...

Doses often need to be adjusted as patients become acclimated to taking GLP-1s, a new class of anti-obesity medication. Research has shown these medications can help adults lose an average of 15% ...

Director Steve Ayson has teamed up with Numan’s in-house creative team on this TV campaign to show the “behavioral and ...

Novo Nordisk launches Wegovy, its anti-obesity drug, in India. Targeting a large obese population, Wegovy aims to improve ...